Veeva Systems Inc. (VEEV)
Veeva Systems provides the digital backbone for the life sciences industry, helping pharmaceutical companies manage clinical trials and regulatory data.
Is Veeva Systems Inc. a good stock for a UK beginner?
The honest version: There's no rating here and nothing for sale. In its favour: High profit margins typical of successful software businesses. Worth weighing: No dividend payments for those seeking regular income.
Is this normal for this company?
Each figure against the range this same company has produced recently. Neither end of a range is the good end.
Share price divided by the earnings actually reported over the four most recent quarters. The range is the same calculation at each of this company's last few results, so roughly the past year.
Profit as a share of sales, from the company's own quarterly statements. The range covers the 5 quarters we hold, and the figure shown is its most recent one.
How these ranges are built
Every number here is the company's own reported figure, not a comparison with other companies. The ranges come from this company's own results and its share price. Where it reports in a different currency from the one its shares trade in, the price-to-earnings range is left out rather than mixing the two.
What does Veeva Systems Inc. do?
Think of Veeva as the specialist software provider that helps drug companies organise the complex paperwork and data required to bring new medicines to market. It charges these companies subscription fees to use its cloud-based platforms. What matters most here is whether they can keep expanding their customer base while holding off larger, general-purpose tech giants.
On our factor screen it looks strongest on quality and momentum, and weakest on income.
- !Pays no dividend - the whole return rides on the share price
- ✓Growing - revenue up about 16% over the year
- ✓Very profitable - turns about 28% of sales into profit
- !High P/E of 42 - big growth is already priced in
- ✓Low debt - a sturdier balance sheet
- Quality screens high
- Value screens low
- Income screens low
Does Veeva Systems Inc. pay a dividend?
No - Veeva Systems Inc. doesn't currently pay a dividend, so the whole return would rest on the share price. Plenty of growing companies reinvest their profits instead of paying them out - neither approach is better or worse, they're just different.
Does Veeva Systems Inc. have more cash or more debt?
It holds about $7.31B in cash against about $103.07M of debt - so it has net cash of about $7.21B. More cash than debt is a cushion: it does not need to borrow just to cover what it owes.
From the latest reported balance sheet. Cash and debt levels change, and some borrowing is normal - this is context, not a judgment.
What do Veeva Systems Inc.'s numbers mean?
How has it performed?
Growth of £1,000, the worst fall, and year by year
Over about 2 years to 2026-09-11. This is the share price only; any dividends would add to it. And it's the USD return - as a UK investor your actual £ return also moves with the exchange rate. Past performance is not a guide to the future, and it could just as easily have fallen.
How much has Veeva Systems Inc. actually fallen?
Over the last 2 years of daily prices, Veeva Systems Inc. fell as much as −51% from a high to a later low. Falls like this are normal when you own a share.
Past falls are not a forecast - it can fall further, or recover.
How has it done year by year?
Calendar-year total return - the share price with dividends reinvested - from adjusted closing prices. The current year is only part-complete. Past returns are not a guide to the future.
A closer look at the numbers
Ownership, earnings history, where the money goes, and the outlook range
Does the share price tell you if it's cheap or expensive?
Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
How much money does Veeva Systems Inc. make?
Revenue and profit by quarter, and how much of each sale turns into profit.
Where does each £100 of Veeva Systems Inc.'s sales go?
A rough split of the latest full-year figures: of every £100 of sales, about £25 covers making the product or service, £47 goes on running costs, tax and interest, and about £28 is left as profit. Margins vary a lot by industry, and one-off items can distort a single year.
When does Veeva Systems Inc. report earnings, and how did recent quarters go?
Veeva Systems Inc. is next scheduled to report on about 2026-11-25 - dates can move, and we don't predict results; this just tells you when to look.
‘Beat’ and ‘missed’ are against what analysts expected, not whether the business is doing well.
| Reported | Expected EPS: The earnings per share analysts expected for the quarter - the average of their forecasts. 'Beating' or 'missing' is measured against this number. | Actual EPS | vs expected |
|---|---|---|---|
| 2026-08-26 | $2.22 | $2.35 | Beat +6% |
| 2026-06-03 | $2.14 | $2.24 | Beat +5% |
| 2026-03-04 | $1.94 | $2.06 | Beat +6% |
| 2025-11-20 | $1.95 | $2.04 | Beat +5% |
| 2025-08-27 | $1.90 | $1.99 | Beat +5% |
| 2025-05-28 | $1.74 | $1.97 | Beat +13% |
Across the last 6 quarters here, Veeva Systems Inc. came in ahead of what analysts expected 6 times. One quarter is noise, not a trend.
See who else reports over the next two weeks →
Where these figures come from
Each quarter a company reports its results against a consensus of analyst forecasts. The figures here are reported versus expected earnings per share from published results; the expectation is that analyst consensus, not our view. Report dates are estimates and can move.
What are the scenarios for Veeva Systems Inc.?
An illustrative range for the year ahead — not a prediction or a price target.
What are the pros, cons and common questions?
The case each way, and the questions people ask
Veeva becomes the essential global standard for all medical data management.
Technological obsolescence or a major shift in how drugs are developed.
What are the pros and cons of Veeva Systems Inc.?
A balance check, not a score or verdict.
- High profit margins typical of successful software businesses
- Strong position in a niche, essential industry
- Recurring revenue model provides predictable income
- No dividend payments for those seeking regular income
- High valuation relative to current earnings
- Significant share price decline over the past year
- Heavy reliance on the pharmaceutical industry's spending habits
- Potential for large tech competitors to enter the space
- Data security and privacy concerns in the medical field
The write-up's own warning lights — if these start happening, the case above changes.
- A sustained drop in pharmaceutical research and development spending
- A major security breach that damages the company's reputation
Common questions about Veeva Systems Inc.
Does Veeva Systems Inc. pay a dividend?
No - Veeva Systems Inc. does not currently pay a dividend, so the return would rest on the share price. Many growing companies reinvest profits instead of paying them out.
When does Veeva Systems Inc. report earnings next?
Veeva Systems Inc. is next scheduled to report results on about 2026-11-25. Report dates are estimates and can move; this is a diary note for when to look, not a forecast of the outcome.
More in Healthcare
Danaher Corporation
GE HealthCare Technologies Inc.
Insulet Corporation
Stryker Corporation
Mettler-Toledo International Inc.
Abbott Laboratories
IQVIA Holdings Inc.
Henry Schein, Inc.Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-02 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.